Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Aug 06, 2024

BUY
$1.66 - $2.31 $1.25 Million - $1.73 Million
750,643 New
750,643 $1.67 Million
Q3 2023

Nov 14, 2023

BUY
$1.66 - $2.31 $1.25 Million - $1.73 Million
750,643 New
750,643 $1.67 Million

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.